Skip to main content
HR 1566 104th Congress House Taxation Clinical trials Commerce Diseases Drug industry Health Income tax Orphan drugs Pharmaceutical research Science, Technology, Communications Tax credits

To amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions and to provide for carryovers and carrybacks of…

Show full title

To amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions and to provide for carryovers and carrybacks of unused credits.

Introduced: May 3, 1995 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 104th Congress ended
It never became law before the 104th Congress (1995–1996) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 3, 1995
Referred to the House Committee on Ways and Means.
May 3, 1995
Sponsor introductory remarks on measure. (CR E939)
May 3, 1995
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Amends the Internal Revenue Code to extend permanently the tax credit for expenses of clinical testing of certain drugs for rare diseases or conditions. Allows a three-year carryback and 15-year carryforward of unused credit amounts, except that no credit may be carried to a taxable year beginning before January 1, 1995.

What's happening now May 3, 1995

Referred to the House Committee on Ways and Means.

 Related & companion bills 1
  • S 1052 Identical bill A bill to amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certai…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 2 Republican 1
R
Smith, Christopher H.
New Jersey · Jul 21, 1995
 D
Pallone, Frank
New Jersey · Jun 7, 1995
 D
Neal, Richard E.
Massachusetts · May 15, 1995
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1566: To amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions and to provide for carryovers and carrybacks of unused credits.. 104th Congress. Open America. https://openamerica.io/bill/104-HR-1566/
MLA
"H.R. 1566: To amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions and to provide for carryovers and carrybacks of unused credits.." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-HR-1566/.
Bluebook (legal)
H.R. 1566, 104th Cong. (2026), https://openamerica.io/bill/104-HR-1566/.
Markdown link
[H.R. 1566: To amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions and to provide for carryovers and carrybacks of unused credits.](https://openamerica.io/bill/104-HR-1566/)
Report a problem